Cargando…

Attempt to Predict A/T/N-Based Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Using a Peripheral Blood DNA Methylation Clock

BACKGROUND: Although aging is the strongest risk factor for the development of Alzheimer’s disease (AD), it remains uncertain if the blood DNA methylation clock, which reflects the effect of biological aging on DNA methylation (DNAme) status of blood cells, may be used as a surrogate biomarker for A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Kenichiro, Mano, Tatsuo, Suzuki, Kazushi, Toda, Tatsushi, Iwatsubo, Takeshi, Iwata, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458568/ https://www.ncbi.nlm.nih.gov/pubmed/32904719 http://dx.doi.org/10.3233/ADR-200205

Ejemplares similares

Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study
por: Sato, Kenichiro, et al.
Publicado: (2021)

Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database
por: Sato, Kenichiro, et al.
Publicado: (2021)

Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive Decline
por: Sato, Kenichiro, et al.
Publicado: (2022)

Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis
por: Sato, Kenichiro, et al.
Publicado: (2019)

Autocorrelation-based method to identify disordered rhythm in Parkinson’s disease tasks: A novel approach applicable to multimodal devices
por: Sato, Kenichiro, et al.
Publicado: (2020)

Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database
por: Sato, Kenichiro, et al.
Publicado: (2021)

Need of care in interpreting Google Trends-based COVID-19 infodemiological study results: potential risk of false-positivity
por: Sato, Kenichiro, et al.
Publicado: (2021)

Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning–based 2D pose estimator
por: Sato, Kenichiro, et al.
Publicado: (2019)

The past, present, and future of disease-modifying therapies for Alzheimer’s disease
por: SUZUKI, Kazushi, et al.
Publicado: (2017)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
por: Kasuga, Kensaku, et al.
Publicado: (2022)

Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial‐Ready Cohort study
por: Sato, Kenichiro, et al.
Publicado: (2021)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Chronic cerebral hypoperfusion shifts the equilibrium of amyloid β oligomers to aggregation-prone species with higher molecular weight
por: Bannai, Taro, et al.
Publicado: (2019)

Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
por: Kurihara, Masanori, et al.
Publicado: (2019)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
por: Suzuki, Kazushi, et al.
Publicado: (2020)

Neuron-specific analysis of histone modifications with post-mortem brains
por: Koshi-Mano, Kagari, et al.
Publicado: (2020)

Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy
por: Kakumoto, Toshiyuki, et al.
Publicado: (2023)

Gait improvement after levofloxacin administration in a progressive supranuclear palsy patient
por: Kurihara, Masanori, et al.
Publicado: (2020)

Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Iwata, Atsushi, et al.
Publicado: (2018)

Isolated Body Lateropulsion in Supplementary Motor Area Infarction
por: Ueda, Kunihiro, et al.
Publicado: (2020)

Isolated Abducens Nerve Palsy Caused by Anterior Inferior Cerebellar Artery Compression
por: Hara, Ryo, et al.
Publicado: (2022)

Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters
por: Fernström, Johan, et al.
Publicado: (2017)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters
por: Isung, J, et al.
Publicado: (2012)

Clinical Characteristics of Neuronal Intranuclear Inclusion Disease-Related Retinopathy With CGG Repeat Expansions in the NOTCH2NLC Gene
por: Nakamura, Natsuko, et al.
Publicado: (2020)

Central and peripheral circadian clocks and their role in Alzheimer's disease
por: Chauhan, Ruchi, et al.
Publicado: (2017)

Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
por: Silverberg, Gerald, et al.
Publicado: (2006)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease
por: Barichello, Tatiana, et al.
Publicado: (2019)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
por: Do, Khanh V., et al.
Publicado: (2022)

Differential Effect of HDAC3 on Cytoplasmic and Nuclear Huntingtin Aggregates
por: Mano, Tatsuo, et al.
Publicado: (2014)

Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuchen, et al.
Publicado: (2023)

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease
por: Kramberger, Milica Gregoric, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_67p20d43uod8up35lfge27njda